title: Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
abstract: The lack of natural killer (NK) cell-specific markers, as well as the overlap among several common surface antigens and functional properties, has obscured the delineation between NK cells and dendritic cells. Here, novel subsets of peripheral blood CD3/14/19(neg) NK cells and monocyte/dendritic cell (DC)-like cells were identified on the basis of CD7 and CD4 expression. Coexpression of CD7 and CD56 differentiates NK cells from CD56+ monocyte/DC-like cells, which lack CD7. In contrast to CD7+CD56+ NK cells, CD7(neg)CD56+ cells lack expression of NK cell-associated markers, but share commonalities in their expression of various monocyte/DC-associated markers. Using CD7, we observed approximately 60% of CD4+CD56+ cells were CD7(neg) cells, indicating the actual frequency of activated CD4+ NK cells is much lower in the blood than previously recognized. Functionally, only CD7+ NK cells secrete gamma interferon (IFNgamma) and degranulate after interleukin-12 (IL-12) plus IL-18 or K562 target cell stimulation. Furthermore, using CD7 to separate CD56+ NK cells and CD56+ myeloid cells, we demonstrate that unlike resting CD7+CD56+ NK cells, the CD7(neg)CD56+ myeloid cells stimulate a potent allogeneic response. Our data indicate that CD7 and CD56 coexpression discriminates NK cells from CD7(neg)CD56+ monocyte/DC-like cells, thereby improving our ability to study the intricacies of NK-cell subset phenotypes and functions in vivo.
authors.affiliation: Division of Experimental Medicine, Department of Medicine, University of California, San Francisco;
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Milush
authors.forename: Brian R
authors.initials: BR
authors.lastname: Long
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Snyder-Cappione
authors.forename: Amedeo J
authors.initials: AJ
authors.lastname: Cappione
authors.forename: Vanessa A
authors.initials: VA
authors.lastname: York
authors.forename: Lishomwa C
authors.initials: LC
authors.lastname: Ndhlovu
authors.forename: Lewis L
authors.initials: LL
authors.lastname: Lanier
authors.forename: Jakob
authors.initials: J
authors.lastname: Michaëlsson
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Nixon
mesh_terms: D000328:Adult; D017951:Antigen Presentation; D019011:Antigens, CD7 / Q000032:analysis*; D015704:CD4 Antigens / Q000032:analysis*; D019002:CD56 Antigen / Q000032:analysis*; D002469:Cell Separation; D003594:Cytoplasmic Granules / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000737:chemistry / Q000145:classification* / Q000276:immunology; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000494:pharmacology; D020382:Interleukin-18 / Q000494:pharmacology; D020014:K562 Cells / Q000276:immunology; D007694:Killer Cells, Natural / Q000737:chemistry / Q000145:classification* / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D007959:Lymphocyte Culture Test, Mixed; D009000:Monocytes / Q000737:chemistry / Q000145:classification* / Q000276:immunology; D019707:Receptors, Chemokine / Q000032:analysis; D054340:Receptors, KIR / Q000032:analysis
chemical_list: D019011:Antigens, CD7; D015704:CD4 Antigens; D019002:CD56 Antigen; D020382:Interleukin-18; D019707:Receptors, Chemokine; D054340:Receptors, KIR; D018664:Interleukin-12; D007371:Interferon-gamma